The Myeloma Institute has seen more than 11,000 patients since its founding in 1989. We are one of the largest centers in the world for research and clinical care related to multiple myeloma and related disorders.
Our internationally recognized physicians and scientists use state-of-the-art technologies to develop innovative treatments tailored to each patient’s specific disease.
The Myeloma Institute has received $10 million dollars to create the Bart Barlogie Center for Molecular Diagnostics and establish the Celgene Distinguished Endowed Chair in Molecular Therapeutics. Press Release.
Since 1989, our mission has been guided by one enduring principle: CURE. UAMS Myeloma Institute for Research and Therapy is a world leader in multiple myeloma research and treatment. Our team of dynamic scientists and clinicians translates advances from the laboratory into novel clinical treatments, continually expanding the boundaries of myeloma research and therapy toward cure for all patients. The Myeloma Institute has pioneered many breakthrough developments and discoveries. Read more about our significant firsts.